Skip to content
Screener

Asset turnover at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.3×0.0×
ALN
Alnylam PharmaceuticalsALNY
0.9×+0.4×
Assembly Biosciences logo
Assembly BiosciencesASMB
0.4×+0.1×
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
+0.9×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.6×+0.1×
Beam Therapeutics logo
Beam TherapeuticsBEAM
0.1×+0.1×

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

Based on trailing twelve months.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047

FAQ

What is Arrowhead Research's asset turnover?
Arrowhead Research (ARWR) reported asset turnover of 0.3× in Q1 2026.
How has Arrowhead Research's asset turnover changed year-over-year?
Arrowhead Research's asset turnover decreased by 24.9% year-over-year, from 0.4× to 0.3×.
What is the long-term trend for Arrowhead Research's asset turnover?
Over 4 years (2021 to 2025), Arrowhead Research's asset turnover has grown at a 30.8% compound annual growth rate (CAGR), from 0.2× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Arrowhead Research's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude